☀️SuryAInvestrade
Market postureCautiousNarrow tape. Fewer, more selective signals by design.See the regime ›
Home / Research / COHR
Stock Thesis

COHR: Stock thesis & analysis

As of 09-01-2026

📁 From our research archive: this thesis was generated on 09-01-2026 and may not reflect our current view. See the latest research →

Below gradeOVERWEIGHT · sector12-month horizonMacro: NEUTRALSmart money: Tier BOn track · -4.1%

Coherent shows genuinely weak fundamentals at a rich price: ROE under 8%, negative FCF margin, and a P/E above 64x on an 11.8% operating margin do not support the current valuation even with Technology as an overweight sector. Smart-money confirmation is thin (2 funds, persistence but no cluster) and short interest is rising 15% month-over-month, both consistent with skepticism about durability of the growth story rather than simple under-coverage. The late-cycle credit warning in the macro overlay further argues against paying up for a name whose earnings quality (negative FCF, high leverage at 31.6x D/E) is already stretched.

Catalysts to watch

  • Next quarterly earnings report — watch for FCF margin inflection to positive territory
  • Potential resolution/clarity following the disclosed officer/director change
  • Analyst initiations (5 in past 30 days) could shift sentiment if upgraded post-earnings

Key risks

  • P/FCF is not meaningful given negative free cash flow margin, complicating valuation support
  • P/E of 64x embeds aggressive growth expectations versus a 7.98% ROE
  • Short interest up 15.4% month-over-month signals building bearish positioning
  • Recent officer/director change disclosed in 8-K adds near-term governance uncertainty
  • Elevated D/E of 31.6x raises balance sheet risk if margins compress further

What would change the view

  • Stock breaks below $245.00 (below recent support and near 8% drawdown from current)
  • FCF margin remains negative for two additional consecutive quarters
  • Op margin falls below 10% for two consecutive quarters, indicating margin deterioration rather than the assumed improvement

More AI stock thesis reports

Browse all public research →

Not financial advice. This is the published output of an AI-driven, human-in-the-loop research process on a paper (simulated) account: informational only, not personalized investment advice, and not a solicitation to buy or sell any security. Past performance does not guarantee future results. Do your own research and trade at your own discretion in your own account. See the full disclaimer, terms & privacy.